EFTA00619607.pdf

Revenues $14,000,000 IntelliCell BioSciences Inc. Quarterly Performance Summary $12,000,000 $10,000,000 - $8,000,000 - $6,000,000 - $4,000,000 - $2,000,000 - 5- HurDA $4,500,000 $4,000,000 $3,500,000 $3,000,000 $2,500,000 — $2,000,000 $1,500,000 $1,000,000 $500,000 $ Mar-11 Jun-11 Sep-11 Dec-11 Mar-12 Jun-12 Sep-12 Dec-12 gesEllITDA $(444,675) $(601,879) $(242,119) $233,061 $606,203 $1,501,986 $2,588,991 $3,891,264 STotal Revenues $183,520 $433,920 $1,685,600 $3,345,380 $4,788,440 $6,791,220 $9,190,300 $11,717,980 $(500,000) $(1,000,000) Confidential Quarterly Performance Chart IntelliCell Financial Plan US 01-2011 revl.xlsx EFTA00619607 $16,000,000 $14,000,000 $12,000,000 $10,000,000 $8,000,000 $6,000,000 $4,000,000 $2,000,000 ■ Banking ■ Processing Kits-Distributors ■ Equipment Sales - Distributors ■ Licensing Revenues - installations IntelliCell BioSciences Inc. Quarterly Revenue Summary V Mar-11 Jun-12 Sep-12 Dec-12 $36,000 $108,000 $232,500 $407,250 $600,000 $826,500 $1,075,500 $1,315,500 $183,520 $3,520 $433,920 $13,920 $183,700 $1,685,600 $354,740 $95,880 $532,220 $758,510 $6,791,220 $264,220 $1,023,450 $9,190,300 $381,300 $1,295,290 $11,717,980 Confidential Quarterly Revenue Chart IntelliCell Financial Plan US 01-2011 revl.xlsx EFTA00619608 IntelliCell Biosciences Inc. North America Division Three Year Launch Plan Forecast Quarterly Income Statement Forecast Start Date: Quarter ended Year ended Quarter ended Year ended 31-Dec-12 Year ended 31-Dec-13 Revenues 31-Mar-11 30-1un-11 30-Seo-11 31-Dec-11 31-Dec-11 31-Mar-12 30-1un-12 30-Seo-12 31-Dec-12 Month 3 Month 6 Month 9 Month 12 Month 12 Month 15 Month 18 Month 21 Month 24 Month 24 Month 36 Licensing Revenues - Installations $ 60,000 5 60,000 5 100,000 $ 100,000 $ 320,000 $ 60,000 $ 60,000 $ 40,000 $ 40000 $ 200,000 $ 160,000 Treatments - Owned Centers 768,000 1,792,000 2,560,000 2,560,000 3,712,000 5,184,000 6,784.000 18,240,000 46,144,000 Processing - Licensed Centers 120,000 360,000 775,000 1,357,500 2,612,500 2,000,000 2,755,000 3,585,000 4,385000 12,725,000 24,037,500 Banking 3,520 13,920 42,600 95,880 155.920 168,440 264,220 381,300 508,980 1,322,940 3,432,920 183,520 433,920 1,685,600 3,345.380 5,648.420 4 788 440 6 791 220 9 190 300 11 717,980 32,487,940 73 774,420 Variable Operating Costs Cost of goods sold 20,960 64,560 183,700 354,740 623,960 532,220 758,510 1,023,450 1,295,290 3,609,470 7,869,660 Licensed Facility Fees 36,000 108,000 232,500 407,250 783,750 600,000 826,503 1,075,500 1,315,500 3.817,500 7,211,250 Sales Commission 27,000 51,000 102,500 160,750 341,250 215,000 290,500 368,500 448,500 1.322,500 2,443,750 Owned Center Operating Costs - 490,800 1,145,200 1,636,000 1,636,000 2,165,200 2,726,400 3,300,400 9.828,000 19,242,400 83,960 223,560 1,009,500 2,067.940 3,384.960 2,983 220 4 040 710 5 193 850 6,359,690 18,577,470 36 767,060 Gross Margin 99,560 210,360 676,100 1,277,440 2,263,460 1,805,220 2,750,510 3,996,450 5,358,290 13,910,470 37,007,360 43% 50% Sales, General & Administrative Costs Marketing 125,798 194,239 206,856 223,450 750,347 257,777 307,846 367,723 430,915 1,364,261 2,457,483 Sales and operations 29,738 29,738 65,875 113,313 238,663 123,853 123,853 207,337 207,337 662,380 1,034,190 Research and development 62,250 255,375 257,375 257,375 832,375 330,375 330,375 329,375 329,375 1,319,500 1,617,500 General and administrative 359,050 396,888 495,163 596,888 1,847,988 668,862 707,050 757,425 786.800 2,920,136 3 461 961 576,835. 876,239 1,025,269 1,191,029 3,669,372 1,380,867 1 469 124 1 661 859 1,754,426 6,266 277 8571,134 Net income (loss) from operations (477,275) (665,879) (349,169) 86,411 (1,405,912) 424,353 1,281,386 2,334,591 3,603,864 7,644,193 28,436,226 Other incomeflexpense) 18.5351 116.6371 (27.0571 (36,353 (88.583) 04,as (51.1611 (57.2791 162.9351 215 376 281,349 Income (loss) before income taxes (485,811) (682,516) (376,226) 50,058 11,494,494) 380,351 1,230,225 2.277,312 3,540,929 7,428,817 28,154,877 Provision for income taxes 42.950 842.605 1.310.144 2.195.700 10,417,305 (485,811) (682,516) (376,226) 50,058 11,494,494) 380,351 1,187,275 1,434,707 2,230,785 5.233,118 17,737,573 NON CONTROLLING INTEREST Net income (loss) $ (085,811) $ (682,516) $ (376,226) $ 50,058 $ 11,494,494) $ 380,351 $ 1 187 275 $ 1,434,707 5 2,230,785 $ 5,233,118 $ 17,737,573 $ 2,588,991 $ 3,891,264 $ 8,588,443 $ 29,850,426 EBITDA $ (044,675) $ (601,879) $ (242,119) $ 233,061 $ (1,055,612 $ 606,203 $ 1,501,986 26% 40% 1-1an-11 CONFIDENTtAL inteuicui Finanaal Man US 022011 rchtdsz Quarterly McceneStatement EFTA00619609 IntelKell Biosciences Inc. North America Division Three Year Launch Plan Forecast Quarterly Income Statement Forecast Start Date: 1-Jan-11 Quarter ended 31-Mar-11 30-Jun-11 30-Seu-11 31-Dec-11 Year ended 31-Dec-11 Quarter ends 31-Mar-12 30-Jun-12 30-Seo-12 31-Dec-12 Year ended 31-Dec-12 Year ended 31-Dec-13 CONFIDENTIAL IntelliCell Financial Pbn US 01-2011 reyttlez Quarterly income Statement EFTA00619610 IntelKell Biosciences Inc. North America Division Three Year Launch Plan Forecast Quarterly Income Statement Forecast Start Date: OPERATING METRICS Cumulative Licensed Markets Cumulative Owned Markets Operating Metrics 1-Jan-11 Quarter ended 31-Mar-11 30-run-ii 30-Sep-II 31-Dec-11 Year ended 31-Dec-11 Quarter ends 31-Mar-12 30-Jun-12 30-Seo-12 31-Dec-12 Year ended 31-Dec-12 Year ended 31-Dec-13 CONFIDENTIAL intelliCell Financial Pbn US 01-2011 revl.the Quarterly Incase Statement EFTA00619611 IntelWell Biosciences Inc. North America Division Three Year Launch Plan Forecast Quarterly Balance Sheet Forecast Start Date: 1-tan-11 Quarter ended Year ended Quarter ended Year ended I 31-Dec-12 Year ended 31-Dec-13 ASSETS CURRENT ASSETS 31-Mar-11 30-Jun-11 30-Seo-11 31-Dec-11 31-Dec-11 31-Mar-12 30-Jun-12 30-Sep-12 31-Dec-12 Cash $ 4,051,450 $ 3,221,336 $ 2,535,787 $ 2,328,725 $ 2,328,725 $ 2,406,825 $ 3,266,302 $ 5,212,967 $ 7.633.322 5 7,633,322 $ 26,658,203 Accounts receivable 19,115 41,123 169,218 282,613 282,613 400,395 574,910 754,633 952.401 952,401 1,775,027 Other recievables - - - - - - - Inventory 19,200 48,000 135,200 228,000 228,000 374,400 510,400 648,030 786.400 786,400 1,232,000 Prepaid expenses 18,218 31,690 46,434 41,364 41,364 84,272 93,621 102,799 105,893 105,893 152,515 Total current assets 4,107,982 3,342,149 2,886,639 2,880,703 2,880,703 3,265,892 4,445,233 6,718,399 9,478,017 9,478,017 29,817,746 PROPERTY AND EQUIPMENT Furniture and fixtures 20,000 25,000 35,000 42,500 42,500 45,000 45,000 55,000 55,000 55,000 57,500 Equipment and computers 12,000 15,000 46,000 50,500 50,500 52,000 127,000 133,000 133,000 133,000 134,500 Center furnishings and equipment 620,000 1,240,000 2,060,000 2,840,000 2,840,000 3,540,000 4,240,000 4,900,000 5,560,000 5,560,000 7,540,000 652,000 1,280,000 2,141,000 2,933,000 2,933,000 3,637,000 4,412,000 5,088,000 5,748,000 5,748,000 7,732,000 Accumulated depreciation (32,600) (96,600) (203,650) (350,300) (350,300 (532,150) (752,750) (1,007,150) (1,294.550) (1,294,550) (2,708,750 Property and equipment -net 619,400 1,183,400 1,937,350 2,582,700 2 582 7C0 3,104 850 3,659,250 4,080,850 4,453,450 4,453,450 5,023,250 OTHER ASSETS Other assets $ 4,727,382 $ 4,525,549 5 4,823,989 $ 5,463,403 5 5.463.403 6.370,742 $ 8 104 483 5 10,799,249 5 13,931,467 5 13,931,467 15 34,840,996 LIABIUTIES AND SHAREHOLDER'S EQUITY CURRENT LIABILITIES Current portion - long term debt 83,907 163,473 265,767 356,907 356,907 431,760 501,713 561.353 616.373 616,373 705,553 Accounts payable 14,500 32,500 185,700 309,500 309,500 435,800 580,200 724,700 872,900 872,900 1,432,900 Accrued expenses 24,760 89,608 99,608 109,464 109,464 135,885 145,234 162,938 173,533 173,533 242,547 Income taxes payable - - 42,950 842,605 1,310,144 1,310,144 3,407,186 123,166 285,582 551,075 775 870 775 870 1,003 445 1 270 098 2,291,597 2,972,950 2,972,9501 5,788,186 LONG TERM DEBT 335,627 653,893 1,063,067 1,427,627 1,427,627 1,727,040 2,006,853 2,245,413 2,465,493 2,465,493 I 2,822,213 SHAREHOLDERS EQUITY Common stock 19,500 19,500 19,500 19,500 19,500 19,500 19,500 19,500 19,500 19,500 19,500 Additional paid in capital 4,734,900 4,734,900 4,734,900 4,734,900 4,734,900 4,734,900 4,734,900 4,734,900 4,734,900 4,734,900 4,734,900 Retained earnings (485,811) (1,168,326) (1,544,552) (1,494,494) µ,494,494 (1,114,143) 73,132 1,507.838 3,738.623 3 738 623 21,476,196 4,268,589 3,586,074 3,209,848 3,259,906 3,259,906 3,640,257 4,827,532 6.262,238 8,493,023 8,493,023 26,230,596 54.727.382 5 4.525.549 5 4,823,989 S 5,463,403 5 5,463,403 5 6.370.742 5 8.104.483 5 10,799.249 5 13.931.467 5 13,931,467 $ 34,840,996 CONFIDENTIAL intananfinarcial Plan US 01.2011 (*gbh.% Quante.* lance Vet EFTA00619612 IntelMelt Bloscleixes Inc. North America Division Three Year Launch Dian Forecast Quarterly Cash Flow Forecast Start Date: 1-Jan-11 Quarter ended Year ended 31-Dec-11 Quarter ended Year ended 31-Dec-12 Year ended 31-Dec-13 Cash flows from operating activities: 31-Mar-11 30-hin-11 30-Seo-11 31-Dec-11 31-Mar-12 30-lun-12 30-Seo-12 31-Dec-12 II Net income (loss) (485,811) $ (682,516) $ (376,226) $ 50,058 $ (1,490,494) $ 380,351 $ 1,187,275 $ 1,434,707 $ 2,230,785 5 233 118 $ 17,737,573 Adjustments to reconcile net (loss) to cash provided (used) by operations: Depreciation and amortization 32,600 64,000 107,050 146,650 350,300 181,850 220,600 254,400 287,400 944,250 1,414,200 Amortization of financing costs Change in assets and liabilities: - - Decrease (Increase) in accounts receivable (19,115) (22,008) (128,095) (113,395) (282,613) (117,782) (174,515) (179,723) (197,769 (669,788 (822,626) Decrease (Increase) in inventory (19,200) (28,800) (87,200) (92,800) (228,000) (146,400) (136,000) (137,600) (138,400 (558,400 (445,600) Decrease (increase) in other prepaid expenses (18,218) (13,472) (14,745) 5,070 (41,364) (42,907) (9,349) (9,178) (3,095 (64,529 (46,622) (Decrease) increase in accounts payable 14,500 18,000 153,200 123,800 309,500 126,300 144,400 144,500 148,200 563,400 560,000 (Decrease) increase in accrued expenses 24,760 64,849 10,000 9,856 109,464 26,422 9,349 17,704 10,595 64,069 69,014 (Decrease) increase in income taxes payable - - - - 42,950 799,655 467,538 1,310,144 2,097,042 Net cash provded (used) by operating activities (470,484) (599,947) (336,016) 129,238 (1,277,208) 407,833 1,284,711 2 324 465 2,805,255 6,822,264 20,562,981 Cash flows from investing activities: Initial acquisition of assets Increase in property, plant and equipment (652,000) (628,000) (861,000) (792,000) (2,933,000) (704,000) (775,000) (676,000) (660,000 (2,815,000 (1,984,000) Net cash provded (used) by investing activities (652,000) (628,000) (861,000) (792,000) (2,933,000) (704,000) (775,000) (676,000) 660 000 (2,815,000 (1,984,000) Cash flows from financing activities: Issuance of common stock 4,754,400 - 4,754,400 Increase (decrease) in equipment loans-net 419,533 397 233 511 467 455,700 1 784 533 374,267 349,767 29&200 275,100 1 297 333 445,900 Net cash provded (used) by financing activities 5,173,933 397,833 511,467 455,700 6,538,933 374,267 349,767 298,200 275,100 1,297,333 445,900 Net increase (decrease) in cash 4,051,450 (830,113) (685,550) (207,062) 2,328,725 78,100 859,477 1,946,665 2,420,355 5,304,597 19,024,881 Cash, beginning of period 0 4,051 50 3 221 336 2 535 787 0 2 328 725 2 406 825 3 266 302 5 212 967 2328,725 7 633 322 Cash, end of period li-rth 450 $ 3,221,336 $ 2,535,787 $ 2,328,725 5 2,328,725 $ 2,006,825 $ 3„266 302 $ 5,212,967! $ 7,633,3221 $ 7 633 322 $ 26 658 203 CONFIDENTIAL intelliCen financial Pion US D1-2011 rrel.tx Quarterly Cash flow EFTA00619613 IntelilCell Blosciences Inc. North America Division Monthly Income Statement Forecast Start Date: 1-]an-11 Revenues 31-)an-11 28-Feb-11 31-Mar-11 30-Ant-11 31-May-11 30-Jun-11 31-Jul-11 31-Aue11 30.5ep-11 31-Oct-11 30.Nov.11 31-Dec-11 TotalYE 31-Dec-11 Month 1 Month 2 Month 3 Month 4 Month S Month 6 Month 7 Month 8 Month 9 Month 10 Month 11 Month 12 Month 12 Licensing Revenues -Installations $ 20,000 $ 20,000 $ 20,000 $ 20000 $ 20,000 $ 20000 $ 40,000 $ 40,000 $ 20,000 5 40,000 $ 40,000 $ 20.000 $ 320,000 Equipment Sales-Distributors $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ Treatments-Owned Centers $ - $ - $ - $ - $ - $ - $ 128,000 $ 256,000 $ 384,060 $ 512,000 $ 640,000 $ 640,000 2,560.000 Processing - Licensed Centers $ 20,000 $ 00,000 $ 60,000 $ 90,000 $ 120,000 $ 150000 $ 207,500 $ 265,000 $ 302,500 $ 382,500 $ 462,500 $ 512,500 2,612,500 Processing Kits-Distributors $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - Banking $ 480 $ 1,120 $ 1,920 $ 3,120 $ 4,560 $ 6,240 $ 9,780 $ 14,100 $ 18,720 $ 24,980 $ 32,200 $ 38,700 155,920 40,480 61,120 81,920 113,120 144,560 176,240 385,280 575,100 725,220 959,480 1 174 700 1 211 200 5,648.420 Cost of Sales Cost of goods sold $ 3,440 $ 6,960 $ 10,560 $ 15,960 $ 21,080 $ 27,120 $ 44,490 $ 62,250 $ 76,960 $ 99,290 $ 122,100 $ 133,350 623,960 Licensed Facility Fees $ 6,000 $ 12,000 18.000 $ 27.000 $ 36,000 $ 05,000 $ 62.250 $ 79,500 $ 90,750 114,750 $ 138,750 $ 153,750 783,750 Sales Commission $ 7,00D $ 9,000 $ 11,000 $ 14,000 $ 17,000 $ 20,000 $ 30,750 $ 36,500 $ 35,250 48,250 $ 56,250 $ 56,250 341,250 Owned Center Operating Costs - $ - $ - $ - $ - $ 81,800 $ 163,600 S 245,400 327,200 S 009,000 S 409,000 1,636,000 16 040 27,960 39,560 56,960 74,480 92,120 219,290 341,850 448.360 589.490 726.100 752,350 3 384 960 Gross Margin 24,040 33,160 42,360 56,160 70,080 84,120 165,990 233,250 276,860 369,990 448,600 058,850 2,263.460 Sales, General & Administrative Costs Marketing 36,726 36,932 52,140 59,431 59,746 75,062 62„203 64,101 80,552 67,945 85,097 70,412 750,347 Sales and operations 9,913 9,913 9.913 9,913 9,913 9,913 21,992 21,992 21,892 37,804 37,804 37,704 238,663 Research and development 20,750 20,750 20,750 85,125 85,125 85,125 86,125 86,125 85,125 86,125 86,125 85,125 832,375 General and administrative 119,683 119,683 119,683 130,588 131,150 131,150 163,029 160,092 172,042 201,188 197.875 197,825 1 847 988 187,071 187,278 202,486 289,036 285,933 301,250 333,349 332,309 359,611 393,061 406,901 391,066 3 669 372 Net Income (loss) from operations (163,031) (154,118) (160,126) (232,896) (215,853) (217.130) (167,359) (99,059) (82,751) (23,071) 41,699 67,784 (1,405.912 Other kxometlexpense) (2,893) (2,805) (2,797) (5,642) (5,546) (5,449) (9,179) (9,019) (8,859) (12,339) (12,118) (11,897 (88,583 Income (loss) before Income taxes (165,925) (156,963) (162,923) (238,538) (221,399) (222.579) (176,538) (108,078) (91,609) (35,010) 29,581 55,887 (1,494.494 Provision for Income taxes Income (loss) before non controlling Mines (165,925) (156,963) (162,923) (238,538) (221,399) (222,579) (176,538) (108,078) (91,609) (35,410) 29,581 55.887 (1,494,494 Non controlling interest Net income (loss) $ (165,925) $ (156.963) S (162.923) S (238.538) $ (221,399) $ (222.579) $ (176.538) 5 (108.078) S (91.609) S (35.410) 5 29.581 5 55.887 11,494,494 CONFIDENTIAL Inteilicelinnancialinan05017011reV1.Xla MonthlyineomeStotement EFTA00619614 Intel'Kell Etiosciences Inc. North America Division Monthly Income Statement Forecast Start Date: 1-Jan-11 31-Jan-11 28-Feb-11 31-Mat-11 30-Apr-11 31-May-11 30-Jun-11 31-Jul-11 31-Aut-11 30-Sep-11 31-Oct-11 30-Nov-11 31-Dec-11 OPERATING METRICS Cumulative Licensed Markets 1 2 3 4 5 6 9 12 14 17 20 21 Cumulative Owned Markets 1 1 1 1 1 1 3 3 2 3 3 1 Operating Metrics Total YF 31-Dec-11 21 CONFIDENTIAL intaliCeli Financial Ran US 012011 revl.xla Monthly income Systeme.. EFTA00619615 IntelliCell Bloscientes Int. North America Division Monthly Income Statement Forecast Start Date: Revenues 31-Jan-12 29-Feb-12 31-Mar-12 30-Apr-12 31-May-12 30-Jun-12 31-Jul-12 31-Aua-12 30-Sep-12 31-00-12 30-Nov-12 31-Dec-12 Total N't 31-Dec-12 Month 13 Month 14 Month 15 Month 16 Month 17 Month 18 Month 19 Month 20 Month 21 Month 22 Month 23 Month 24 Month 24 Licensing Revenues-Installations $ 20,000 $ 20,000 $ 20,000 $ 20,000 $ 20,000 S 20,000 S 20,000 $ 20,000 $ - $ 20,000 $ 20,000 $ - $ 200,000 Equipment Saes -Distributors $ - $ $ - $ - $ - S - S - $ - $ - $ - $ - $ - $ Treatments - Owned Centers $ 768,000 $ 896000 $ 896000 $ 1,088000 $ 1,280.000 S 1,344,000 $ 1,568,000 $ 1,792,000 $ 1,820,003 $ 2,080,000 $ 2,336,000 $ 2,368,000 18.240400 Processing - Licensed Centers $ 592,500 $ 672,500 $ 735,000 $ 830,000 $ 925,000 S 1,000,000 $ 1,105,000 $ 1,210,000 $ 1,270,000 $ 1,375,000 $ 1,480,000 $ 1,530,003 12.725400 Processing kits-Distributors $ - $ - $ - $ - $ - S - $ - 5 - $ - 5 - $ - 5 - $ Banking $ 47,120 $ 56340 $ 64,980 $ 76,100 $ 88,220 S 99,900 S 113,480 $ 127,680 $ 140,140 $ 154,960 $ 170,300 $ 183,720 1.322,940 1,427,620 1,644,840 1.715,980 2 014 100 2 313 220 2,463,900 2,806,480 3.149,680 3,234,140 3,629,960 0 036 300 4,081,720 32.487.940 Cost of Sales Cost of goods sold $ 156,760 $ 180,570 $ 194,890 $ 225.250 $ 256,110 $ 277,150 $ 311,940 $ 347,040 $ 364,470 $ 401,480 $ 438,750 $ 455,060 3.609,070 Licensed Facility Fees $ 177,750 $ 201,750 $ 220.500 $ 249,000 $ 277.500 S 300,000 $ 331,500 $ 363,000 $ 381,000 $ 412,500 $ 444,000 $ 459,000 5 3,817,500 Sales Commission $ 64,250 $ 72„250 $ 78,500 $ 88,000 $ 97,500 $ 105,000 $ 115,500 $ 126,000 $ 127,000 $ 142,500 $ 153,000 $ 153,000 1,322,503 Owned Center Operating Costs $ 490,800 $ 572,600 $ 572,600 $ 660,800 $ 749,000 $ 755,400 $ 846,800 $ 938„200 $ 941,400 $ 1,036,000 $ 1,130,600 $ 1,133,800 9.828000 889,560 1,027,170 1,066,490 1,223050 1 380 110 1,437,550 1 605 740 1,774„240 1,813,870 1,992,480 2 166 350 2,200,860 18.577,470 Gross Margin 538,060 617,670 649,490 791,050 933,110 1,026,350 1,200,740 1,375,440 1,420,270 1,637,480 1,839,950 1,880,860 13.910470 Sales, General & Administrative Costs Marketing 76,712 82,143 98,921 98,852 117,619 42284 111,184 119,764 136,775 131,771 156,179 142,965 1,364,261 Sales and operation 41,284 41,28A 41584 491,2 .384 74 41,28al 69,146 69,146 69,046 69,146 69,146 69,046 662.380 Research and development 110,125 110,125 110,125 110,125 110,125 110,125 110,125 110,125 109,125 110,125 110,125 109,125 1,319,500 General and administrative 223,329 222,767 222,767 235,683 235,683 235,683 254,975 251,350 251,100 262,350 262,350 262,100 2 920 136 451,451 456,319 473,097 478,467 485,945 504,712 545,429 550,380 566046 573,391 597,800 583,235 6.266,277 Net income (loss) from operations 86,609 161551 176,393 312,583 447,165 521,638 655,311 825,056 854,224 1,064,089 1,242,150 1,297,625 7.644,193 Other income/(expense) (14,943) (14,667) (14,392) (17583) (17,054) (16,724) (19,474) (19,093) (18,712) (21,411) (20,978) (20,546 (215,376) Income (loss) before Income taxes 71,667 146684 162,001 295,200 430,111 504510 635,837 805,963 835,512 1,042,678 1,221,172 1,277,079 7,428417 Provisi0n for Income taxes 42,950 235,260 298506 309,140 385,791 451,834 472,519 2.195,700 Income (loss) before non controlling intern 71,667 146684 162,001 295,200 430,111 461,964 400,577 507,757 526,373 656,887 769,338 804560 5.233,118 Non controlling interest Net income (loss) 5 71.667 5 146.684 5 162.001 5 295.200 5 430.111 5 461.964 5 400,577 5 507.757 5 526,373 5 656.887 5 769,338 5 804.560 5 5.233.118 CONFIDENTIAL inuNcen Financial Ran US 012011 revl.xla Monthly income %stow. EFTA00619616 InternCell Bloscientes Int. North America Division Monthly Income Statement Forecast Start Date: Total YE 31-Jan-12 29-Feb-12 31-Mar-12 30-Aor-12 31-May-12 30-Jun-12 31-Jul-12 31-Aug-12 3O-Sep-12 31-Oct-12 30-Nov-12 31-Dec-12 OPERATING METRICS Cumulative Licensed Markets 23 25 26 28 30 31 33 35 35 37 39 39 Cumulative Owned Markets 2 2 1 2 2 1 2 2 2 2 Operating Metrics 31-Dec-12 39 CONFIDENT LAI. intaliCeli Financial Ran Us 01.2011 revl.xla Monthly income Systeme.. EFTA00619617 IntNIICNI Blosciences Inc. North America Dh4sion Monthly Income Statement Forecast Start Date: Revenues 31-Jan-13 28-Feb-13 31-Mar-13 30-Aor-13 31-May-13 30-tun-13 31-lui-13 31-Aut-13 30-54n-13 31-Oct-13 30-Nov-13 31-Dec-13 Total U 31-Dec-13 Month 25 Month 26 Month 27 Month 28 Month 29 Month 30 Month 31 Month 32 Month 33 Month 34 Month IS Month 36 Month 36 Licensing Revenues -Installations $ 20,000 $ 20,000 $ - $ 20,000 $ 20,000 $ - $ 20,000 $ 20,000 $ - $ 20,000 $ 20,000 $ $ 160,000 Equipment Sales -Distributors $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ $ Treatments - Owned Centers $ 2,656,000 $ 2,944,000 $ 2,976,000 $ 3,296,000 $ 3,616,000 $ 3,648,000 $ 3,968,000 $ 4,288,000 $ 4,288,000 $ 4,608,000 $ 4,928,000 $ 4,928,003 $ 46,100,000 Processing - Lkensed Centers $ 1,627,500 $ 1,725,000 $ 1,767,500 $ 1,852,500 $ 1,937,500 $ 1,967,500 $ 2,047,500 $ 2,127,500 $ 2,145,000 $ 2,225,000 $ 2,305,000 $ 2.310,003 $ 24,037,500 Processing Kits-Distributors $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - $ - Banking $ 199,720 $ 216,260 $ 230,560 $ 247,220 $ 264,120 $ 278,260 $ 294,680 $ 311,140 $ 324,580 $ 340,580 $ 356,540 $ 369,260 $ 3,432,920 4,503,220 4,905,260 4 974 060 5 415 720 5,837,620 5,893,760 6,330,180 6 746 640 6 757 580 7,193.580 7.609,540 7 607 260 73 774 420 Cost of Sales Cost of goods sold $ 493,060 $ 531,330 $ 546,880 584,810 $ 622,860 $ 636,330 $ 673,340 $ 710,370 719,890 $ 756,690 $ 793,470 $ 800,630 $ 7,869,660 Licensed Facility Fees 488,250 $ 517,500 $ 530,250 555,750 $ 581,250 $ 590,250 $ 614,250 $ 638,250 643,5® $ 667,500 $ 691,500 $ 693,000 $ 7,211,250 Sales Commission $ 167,750 $ 177,500 $ 176,750 $ 190,250 $ 198,750 $ 196,750 $ 209,750 $ 217,750 214,5® $ 227,500 235,500 $ 231,000 $ 2,443,750 Owned Center Operating Costs $ 1,231,600 $ 1,329,400 $ 1,332,600 1,433,600 $ 1,534,600 1,537,800 $ 1,638,800 $ 1,739,800 1,739,8® $ 1,840,800 1,941,800 $ 1,941,800 $ 19,242,400 2,380,660 2,355,730 2 586 480 2,764,410 2 937 460 2,961,130 3,136,140 3,306,170 3 317 6S0 3,492.490 3,662,270 3 666 430 36 767 060 Gross Margin 2,122,560 2.349,530 2,387,580 2,651,310 2,900,160 2,932,630 3,194,040 3,440,470 3,439,850 3,701,090 3,947,270 3,940,830 37,007,360 Sales, General & Administrative Costs Marketing 158,707 168,758 185,378 181,520 192,067 208,371 204,381 214,793 229,966 225,966 251,365 236,208 2,457,483 Sales and operations 72,646 72,646 72,546 79,851 79,851 79,751 96,183 96,183 96,083 96,183 96,183 96,0834 1,034,190 Research and development 135,125 135,125 134,125 135,125 135,125 134,125 135,125 135,125 134,125 135,125 135,125 134,125 1,617,500 General and administrative 275,350 275,350 275,100 288,454 287,517 287,267 291,842 289,717 289,467 300,717 300,717 300,467 3,461,961 641,828 651,879 667,149 684,950 694,560 709,513 727,531 735,818 749,641 757,991 783,390 766,883 8,571,134 Net Income (loss) from operations 1,480,732 1,697,651 1,720,431 1,966,360 2,205,600 2,223,117 2,466,509 2,704,652 2,690,249 2,943,099 3,163,880 3,173,947 28,436,226 Other income/(expense) (23,193) (22,710) (22,226) (24,822) (24,287) (23,752) (23,217) (22,682) (22,146) (24,691) (24,105) (23,518) (281,349] Income (loss) before income taxes 1,457,539 1,674,942 1,698,205 1,941,518 2,181,313 2,199,365 2,443,292 2,681,971 2,668,102 2,918,407 3,139,775 3,150,428 28,154,877 Provision for Income taxes 539,289 619,728 --- 628,336 718,369 807,086 813,765 904,018 992,329 987,198 1,079,811 1,161,717 1,165,658 10,417,305 Income (loss) before non controlling Interes 918,249 1,055,213 1,069,869 1,223,169 1,374,227 1,385,6® 1,339,274 1,689,641 1,680,904 1,838,597 1,978,058 1,984,770 17,737,573 Non controlling Interest Net Income (loss) $ 918.249 5 1,055213 $ 1069.869 $ 1.223,169 5 1,374.227 5 1.385.600 5 153%274 $ 1,689.641 5 1.680,904 5 1,838.597 5 1.978.058 5 1%84,770 $ 17.737,573 CON FIDE NT LAI. intalicen Financial Ran US01.2011 revl.xla Monthly income %stmt.. EFTA00619618 IntelliCeil Blostiences Inc. North America Division Monthly Income Statement Forecast Start Date: Total OPERATING METRICS Cumulative Licensed Midgets Cumulative Owned Markets Operating Metrics 31-Jan-13 28-Feb-13 31-Mar-13 30-Aor-13 31-May-13 30-Jun-13 31-Jul-13 31-Aug-13 30-Sep-13 31-OO-13 30-Nov-13 31-Dec-13 41 43 43 45 47 47 49 51 51 53 55 55 2 2 2 2 2 2 2 2 31-Dee-13 55 CONFIDENT LAI. raciliceli Financial Ran US 01.2011 revl.xla Monthly income Statement EFTA00619619 (nee(Well Blaufences Inc. North America DMsion Monthly Balance Sheet Forecast Start Date: 1-Jan-11 31-lan-11 28-Feb-11 31.nAanll 30.Apn11 31.May-11 30./un.11 31-hd-11 31-out-11 30-See-11 31-064-1.1 30-Nov-11 31-Dec-11 ASSETS CURRENT ASSETS 1-tan-11 Cash $ 0 $ 4,386,038 5 4,225,493 $ 4,051,450 $ 3,690,727 $ 3,463,541 $ 3,221,336 $ 2,770,736 $ 2,649,749 5 2,535,787 $ 2,262,723 $ 2,267,180 $ 2,328,725 Accounts receivable - 9,445 14,261 19,115 26,395 33,731 41,123 89,899 134,190 169,218 223,879 274,097 282,613 Other redevables - - - - - - - - - - Inventory 4 6,400 12,800 19,200 28,800 38,400 48,000 79,200 110,400 135,200 173,600 212,00) 228003 Prepaid expenses (0) 10,511 10,614 18,218 15,874 16,031 31,690 25,260 26,209 46,434 40,131 48,707 41,364 Total current assets 4.412,394 4,263.168 4,107.982 3,761,796 3,551,702 3,342,149 2,965.096 2,920,548 2,886,639 2,700,332 2,801,983 2,880,703 PROPERTY AND EQUIPMENT Furniture and fixtures 20000 20,00) 20,000 25,00) 25,000 25,000 35,00) 35,000 35,030 42,500 42,500 42,501 Equipment and computers 12,000 12,00) 12,000 15,00) 15,000 15,000 46,00) 46,000 46,030 50,500 50,500 50.301 Center furnishings and equipment 620000 620,00D 620,00D 1,240,000 1,240,000 1,240,000 2,060.000 2.060,000 2,060,000 2,840,000 2,840.000 2,840,000 652000 652,00) 652,000 1,280,000 1,280,000 1,280,000 2,141,00) 2,141,000 2,141,000 2,933,000 2,933,000 2,933,000 Accumulated depreciation (10,867) (21.733) (32,600) (53.933) (75,267) (96,600) (132.283) (167,967) (203,650) (252,533) (301.417) (350.300) Property and equipment -net 641,133 630,267 619,400 1,226,067 1,204,733 1,183400 2,008,717 1,973 33 1,937,350 2,680,467 2,631,583 2,582,700 OTHER ASSETS Other assets - $ 5,053,528 5 4,893,434 5 4,727,382 5 0,987,863 $ 4,756,436 $ 4,525,549 $ 0,973,813 5 4,893 581 5 4,823,989 $ 5,180,799 $ 5,433,566 5 5,463,403 LIABILITIES AND SHAREHOLDERS EQUITY CURRENT UABILITIES Current portion- long term debt 86,81:0 85,353 83,907 169,260 166,367 163,473 275,380 270,573 265,767 370,160 363,533 356,907 Note payable - - - - Accounts payable 6,51:0 10,500 14,500 20,500 26,500 32,500 87.400 139,800 185,703 245,100 302,00) 309.500 Accrued expenses 24,552 24,656 24,760 91,011 89,450 89,608 99,977 99,457 99,608 110,461 109,881 109,464 Defrerred revenue Income taxes payable 117,852 120,509 123,166 260,771 282,317 285,582 462,757 509,831 551,075 725,721 775,414 775,870 LONG TERM DEBT 347,200 341,013 335,627 677,040 665,467 653,893 1,101,520 1,082,293 1,063,067 1,480,640 1,454,133 1,427,627 NON CONTROLLING INTEREST SHAREHOLDER'S EQUITY Common stock 19,500 19,500 19,50D 19,500 19,500 19,500 19,500 19,500 19,500 19,500 19,500 19.500 Additional paid in capital 4,734,900 4,734,900 4,734,900 4,734,90) 4,734,900 4,734,900 4,734,90) 4,734,960 4,734,900 4,734,900 4,734,900 4,734,900 Retained earnings (165,925) 22,888 (485.811) (724,349) (945,747) ,168,32 (1,344.864) (1,452,943) (1,544,552) (1,579.962) .S50,381 (1,494,494) 4,586,475 4,431,512 4,268,589 4,030,051 3,808,653 3,586,074 3,409,536 3,301,457 3,209,848 3,174,438 3,204,019 3,259.906 5 $ 5,053,528 5 4,893,434 $ 4,727,382 $ 4,987,863 $ 4,756,436 $ 4,525,549 $ 4,973,813 $ 4,893,581 5 4,823,989 $ 5,320,799 $ 5.433,566 $ 5,463,403 CONFIDENTIAL trpeliCellianuncial Plan US 011011 (Mahn MOMMY Oalin<t Sheet EFTA00619620 IntelliCell Biosciences Inc. North America Division Monthly Balance Sheet Forecast Start Date: ASSETS CURRENT ASSETS 31-1an-12 29-Feb-12 31-Mar-12 30-Apr-12 31-May-12 30-Jun -12 31-Jul-12 31-Aut-12 30-Sen-12 31-Oct-12 30-Nov-12 31-Dec-12 Cash $ 2,134,772 $ 2,286,707 $ 2,406,825 $ 2,400,697 $ 2,817,780 $ 3,266,302 $ 3,672,251 S 4,468,254 $ 5,212,967 $ 5,787,936 $ 6,695,623 $ 7,633,322 Accounts receivable 333,111 383,796 403,395 469,957 539,751 574,910 654,845 734,925 754,633 846,991 934,803 952,401 Other reclevables - - - - - - - - - - Inventory a 304,800 324,800 374,400 424,000 454,400 510,400 566,400 588,800 648,000 707,200 726,400 786,400 Prepald expenses 73,167 75,882 84,272 80,498 84,237 93,621 90,403 94,693 102,799 100,696 112,901 105,893 Total current assets 2,845,851 3,071,185 3,265,892 3,375,152 3,896,169 4,445.233 4.983,899 5,886,672 6718,399 7,442,823 8,469 726 9,478,017 PROPERTY AND EQUIPMENT Furniture and fixtures 45,000 45,000 45)X0 45,030 45,000 45,000 55,01:0 55,000 55,000 55,000 55,003 55,000 Equipment and computers 52,000 52,000 52,000 127,000 127,000 127,000 133,01:0 133,030 133,000 133,000 133,000 133,000 Center furnishings and equipment 1540.000 3.540,000 3,540= 4,240,030 4,240,000 4,240.000 4.930,030 4,50),C00 4,900,000 5,560.00) 5,500,030 5,560.000 3,637,000 3,637,000 3,637,030 4,412,000 4,412,000 4,412,000 5,088,030 5,088,030 5,088,000 5,748,000 5,748,030 5,748,000 Accumulated depredation 1410,917) 1471,533) (532,150) (605,683) (679,217) 1752,7501 (837,550) (922.350) 1,007 150 (1,102.950) (1.198,750) (1.294.550) Property and equipment -net 3,226,083 3,165,467 3,104,850 3,806.317 3,732,783 3,659,250 4,250 450 4,165,650 4,080,850 4,645.050 4.549,250 4,453.450 OTHER ASSETS Other assets $ 6,071,934 S 6,236,652 $ 6,370,742 $ 7,181,468 $ 7628,952 S 8,104,483 S 9,234,349 $ 10,052,322! $ 10,799,249 $ 12,087,873 S 13,018,976 $ 13,931,467 LIABIUTIES AND SHAREHOLDER'S EQUITY CURRENT LIABIUTIES Current portion- long term debt 448280 440,020 431,760 521.300 511,607 501,713 584,220 572,787 561,353 642,320 629,347 616,373 Note payable - - - - Accounts payable 366,400 423,300 435,8C0 498,900 562,000 580,200 646,903 713,600 724,700 795,500 863,803 872,900 Accrued expenses 132,562 134,996 135,885 139,612 143,351 145,234 160,030 162,508 162,938 168,511 173,215 173,533 Defrerred revenue Income taxes payable 42,950 278 210 576416 842,605 993,137 1,146,764 1,310,144 947,242 998,316 1,003,445 1,160,012 1,216,958 1,270,098 1,669,360 2,025,310 2.291,597 2,599,468 2,813,126 2,972,950 LONG TERM DEBT 1,793,120 1,760,080 1,727,040 2,086,030 2,046,427 2,006,853 2,336,880 2,291,147 2.245,413 2,569,280 2,517,387 2,465,493 NON CONTROWNG INTEREST SHAREHOLDER'S EQUITY Common stock 19,500 19,500 19,500 19.300 19,500 19,500 19,503 19,500 19,500 19,500 19,51:0 19,500 Additional paid in capital 4,734,900 4,734,900 4,734,930 4,734.900 4,734,900 4,734,900 4,734,903 4,734,900 4,734,900 4,734,900 4,734,900 4,734,900 Retained earnings ,422,82 (1,276.144) (1,114,143) (818.944) (388,832) 73,132 473,709 981,465 1.307,838 2,164,725 2,934,064 3,738,623 3,331,572 3,478,256 3,640,257 3,935,456 4,365,568 4,827,532 5,228,109 5,735,865 6.262,238 6,919,125 7 686 464 8,493,023 $ 6,071,934 $ 6,236,652 $ 6,370,742 $ 7,181,468 $ 7,628,952 $ 8,104,483 $ 9,234,349 $ 10,052,322 $ 10,799,249 $ 12,087,873 ..-f $ 13,018,976 $ 13,931,467 CONFIDENTIAL IntelliColl Financial Plan US01.2011 revIalsa Monti* Canoe Sheet EFTA00619621 IntelliCell Biosciences Inc. North America Division Monthly Balance Sheet Forecast Start Date: ASSETS CURRENT ASSETS 31-1an-13 28-Feb-13 31-Mar-13 30-Apr-13 31-May-13 30-1un-13 31-1o1.13 31-Aue-13 30-Sep-13 31-Oct-13 3O-Nov-13 31-Dec-13 Cash $ 8,025,145 $ 9,219.391 $ 10,876,702 S 12,04%371 $ 13,595,304 $ 1%130,699 $ 16,816,439 $ 18,691,587 S 2%31%696 $ 22,299,027 $ 24,447,716 $ 26,658,203 Accounts receivable 1,050,751 1,104.361 1,160,614 1,263,668 1,362,111 1,375,211 1,077,042 1,574,216 1.37%769 1,678,502 1,775,559 1,775,027 Other reclevables - - - - - inventory 4 846,40D 863,200 922,4W 981,600 990,400 1,052,00D 1,109,600 1,115,2W 1,172,800 1,230,400 1,232,000 1,232,000 Prepaid expenses 114,165 119,190 127,100 12%571 130,845 138,596 137,002 142,207 14%394 147,794 160,494 152.315 Total current assets 10,036.461 11,346.342 13,086,816 14,411,210 16,082,700 17,696.506 19,540,082 21,523 210 23,41%659 25,355,724 27,615,769 29,817,746 PROPERTY AND EQUIPMENT Furniture and fixtures 55,00D 55,000 55,000 57,500 57,5W 57,500 57.300 57,5W 57,500 57,5W 57,500 57300 Equipment and computers 133,00D 133,000 133,000 134500 134,530 134,500 134.300 130,5W 134,500 134,5W 134,500 134,500 Center furnishings and equipment 6,220.00D 6,220,000 6,220,030 6,88%000 6,680,030 6,880,000 6,880,000 6,880,030 6,88%000 7,540030 7,540,000 7,540,000 6,408,000 6,408,000 6,408,030 7,072,000 7,072,030 7,072,000 7,072,000 7,072,030 7,072,000 7,732,030 7,732,000 7,732,000 Accumulated depreciation (1,401,350) (1,508,150) (1,614,950) 1 732 817 (1,850,683) (1,968,550) (2,086,017) (2,204,283) 2 322 150 (2,451,017) (2,579.883) (2,708,750) Property and equipment -net 5,006,650 0,899,850 4,793,050 5,339,183 5,221,317 5,103,450 4,985583 4,86 17 4,749,850 5280,983 5,152,117 5,023_250 OTHER ASSETS Other assets S 15,043 11 $ 16,246.392 $ 17,879,866 $ 19 750,394 $ 21,304,017 $ 22,799,956 5 24,525,666 $ 26,390 27 S 28,165,509 30,636,707 $ 32,767,885 S 30,840396 LIABILITIES AND SHAREHOLDER'S EQUITY CURRENT UABILITIES Current portion - long term debt 695,800 681,287 666,773 744,660 728,607 712,553 696.300 680,447 664,393 740,740 723,147 705.553 Note payable - - - - Accounts payable 943,800 1,012,200 1,O19,8W 1,089,800 1,157,3W 1,162,400 1,231,000 1,297,900 1,298,900 1,367,900 1,434,400 1,432,900 Accrued expenses 197,229 202,255 202,490 211,336 216,141 216,217 228,271 232,414 231,926 238,001 243,200 202.347 Defrerred revenue income taxes payable 1,011,809 1,159,018 1,787,354 1,966,434 2,153 791 2 339 220 2,524,869 2,710112 2,883,545 3,059,338 3,228,725 3,407,186 2,848,636 3,054,759 3,676,417 4,012,229 4,255,838 4,430,391 4,681,040 4,920,873 5,078,764 5,005,979 5,629,472 5,788,186 LONG TERM DEBT 2,783,200 2,725,147 2,667,093 2378,640 2,914,427 2,850,213 2,786,000 2,721,787 2,657,573 2,962,960 2,892,587 2,822,213 NON CONTROLUNG INTEREST SHAREHOLDER'S EQUITY Common stock 19,500 19300 19,5W 19,500 19,5W 19,500 19.300 19,5W 19,500 19,5W 19,500 19,500 Additional paid in capital 4,734,900 4,734,900 4,734,900 4,734,900 4,73%900 4,734,900 4,734,900 4,734,900 4,734,900 4,73%900 4,734,900 4,734,900 Retained earnings 4,656,873 5,712,086 6,781,956 8,005,125 9,379,352 10,764,952 12,304,226 13,993 867 15 674,772 17,513,368 19,491,426 21,476,196 9,411,273 10,466,486 11,536,356 12,759,525 14,133,752 15,519,352 17058 626 18,748,267 20,429,172 22,267,768 24,245,826 26,230.596 $ 15,043,111 $ 16,246.392 $ 17,879,866 S 19,750,394 $ 21,304,017 $ 22,799,956 $ 24,525,666 $ 26,390,927 S 28,165,509 $ 30,636,707 $ 32,767,885 $ 30,800,996 CONFIDENTIAL IntelliColl Financial Plan US01•2011 revIalsa Montdy Bounce Sheet EFTA00619622 Intel'.Cell Blosciences Inc. North America Division Overhead Expense 9091C9411 Stan Date: 1-lan-11 31-Jan-11 28-Feb-11 31-Mar-11 30-Apr-11 31-May-11 30-3un-11 31-Jul-11 31-Auk-11 30-Sep-11 31-Ott-11 30-Nov-11 31-Crec-11 Total Yawl Yoe/ To° Rats /SW 199 Month 1 Month 2 Month) Month 0 Month 5 Month 6 Month 7 Month 8 Month 9 Month 10 Month 11 Month 12 Month 12 Research and darefoonirmr Salaries $ 15,000 5 15,4300 $ 15,000 $ 27,500 $ 27,500 $ 27,500 $ 27,500 $ 27,500 $ 27,500 $ 27,500 $ 27,5[0 $ 27,500 $ 292,500 Taxes 2,250 2,250 2,250 4,125 4,125 4,125 4,125 4,125 4,125 4,125 4,125 4,125 43,875 and tenerds CuleiJe seMcee 50,000 50,M0 50,000 50,000 50,000 50,000 50,000 50,000 50,000 450,000 Travd IL antortainmani ZOO 2,500 2,500 2,5[0 2.500 2,500 2,500 2,500 2,500 2.500 2,500 2,5[0 2,500 30,000 Msedlaneeue 50%. 5.06 50% 1,000 1,000 1,000 1,000 1,030 1,000 2,000 2,000 1,000 2,000 2,000 1,000 16,000 $ 20,750 5 20,750 S$ 750 $ 85,125 5 85,125 $ 85,125 5 86,125 $ 86,125 $ 85,125 $ 86,125 S5 5 85,125 $ 832,375 Matting Satia, Markebng $ 14,583 5 10,583 $ 14,583 5 25,000 5 25,030 $ 25,000 $ 25,000 $ 25,000 5 25,000 $ 25,000 $ 25,0[0 $ 25,000 $ 268,750 Taxes and beagle 150% ISM& 150% 2,188 2,188 2,188 3,750 3,750 3,750 3,750 3,750 3,750 3,750 3,750 3,750 40,313 Admilmnamdreci 3.011 LS% 405 611 819 1,131 1,046 1,762 3,853 5,751 7.252 9,595 11,747 12,112 56,484 PrOCbCI OaCkartvelaPtics 2100 2100 5000 2,500 2,500 2,5[0 2,500 2,500 2,500 2,500 2,500 2.500 2,500 2,5[0 2,500 30,000 Pub,: ratan:ins Id% 1.5% 1.5% 10,000 10,000 10,0[0 20,000 20~ 20,000 20,000 20,000 20,000 20,000 20,0[0 20,000 210,000 Tier» shows 15,00) 15,000 15,000 15,0[0 60,000 Webste hostng & margerance 210> 1% 2,000 2,000 2,0[0 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 24,000 Travel 4 eronainnnent 910> 7500 19:00 5,000 5,000 5,00) 5,000 5,030 5,000 5,000 5,000 5,000 5,000 5,0[0 5,000 60,000 Miscellaneous 0.3% 0.5% 03% 50 50 50 50 50 50 100 100 50 100 !CO 50 800 5 36,726 5 36,932 $ 52,140 5 59,031 5 59,746 $ 75,062 5 62,203 $ 64,101 5 80,552 $ 67,945 351:97 5 70,412 $ 750,347 Sales and operations Satanez.Sales and Demeans $ 3,750 5 3,750 $ 3,750 5 3,750 $ 3,750 $ 3,750 $ 14,167 $ 14,167 5 10,167 $ 27,917 $ 27,917 5 27,917 $ 148,750 Taxes and beneOls 563 563 563 563 563 563 2,125 2,125 2,125 0.188 4,188 0.188 22,313 Solos 6 craning rrotenah IOC° 1000 5000 1,000 1,000 1,0[0 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 12,000 Trani and eronanment 2500 5000 7500 2,500 2.500 2,5[0 2,500 2,500 2,500 2,500 2,500 2,500 2.500 2,5[0 2,500 30,000 IT oasis 1000 20:0 1000 2,000 2,000 2,000 2,000 2,000 2,000 2,000 200I) 2,000 2,000 2,000 2,000 24,000 Miscellaneous 03% 0.5% 0.5% 100 100 100 100 100 100 200 2013 100 200 200 100 1.603 9913 9.913 9913 9.913 5 9913 9.913 5 21992 5 21.992 211392 37.804 37204 37.704 238663 090~1 IIIC «imit499•999 Sdatias. G 3 A $ 70,000 5 70.000 $ 70,0[0 $ 70.000 $ 70,030 $ 70,000 $ 79,167 $ 79,167 5 79,167 $ 87,500 $ 87,5[0 5 87,500 $ 920,000 Tams and WINO 10,500 10,500 10,5[0 10.500 10,500 10,500 11,875 11,875 11,875 13,125 13,125 13,125 138,000 Decmcialian & amcnitatian 10,867 10,867 10,867 21,333 21,333 21,333 35,683 35,683 35,683 48.883 48,883 48.883 350,300 Ref/aging 150% - - 3.038 - 2,938 - 3,313 - 9,688 Insurance 10% 267 267 267 267 267 267 267 267 267 267 267 267 3.200 Legal 6 «taunting 7000 e000 10000 7,000 7,000 7,0[0 7.000 7,030 7,000 7,000 7,000 7,000 7,000 7,0[0 7,000 84,000 Once expanses 500 600 0,000 4,000 &MO 4.500 4,500 4,500 6,500 6,500 6.500 8,000 8,000 8,000 69,000 Ren1Utlites 8000 W000 20000 8,000 8.000 8,000 8.000 8,030 8,000 8,000 8,000 20,000 20,000 20,0[0 20,000 144,000 Game/medians 500 4,000 4,000 &MO 0.500 4,500 4,500 6,500 6,500 6.500 8,000 8,000 8,000 69,000 Trav« 6. entertainment 5000 10000 t0000 5,003 5,000 5,0[0 5.000 5,000 5,000 5,000 5,000 5,000 5,000 5,0[0 5,000 60,000 bescatineous 0.1% Oft 03% 50 50 50 50 50 50 100 100 50 100 100 50 800 , $ 119683 5 119,683 $ 119,683 $ 130.588 $ 131,150 $ 131,150 $ 163029 $ 160,092 $ 201,188 $ 197,875 5 197,825 Uall13 $ 166321 $ 166,528 $ 181,736 5 203.931 200,908 $ 216,125 $ 247,221 $ 206,180 $ 270,486 $ 306,936 $ 320,776 $ 305,941 $ 2,836,997 InteliCenFinanSi Plsn IA 01-2011 revl Monthly 0~0M Bude01 CONFIDENTIAL EFTA00619623 IMelliCell Biosclences Inc. North America Division Overhead Expense Forecast Start Date: Research and development Selena, Taxes and tenets Outside SeniCeS Travel& enterlanmenl MISCOMMuS Markeling Satanes- Markeing Ta, eS 814 bere'CS Adverb:no-Mita producipackefintVraPbees Pible .Nations Trade Shows Welaske hosting & maieenance Travels emerlainmen1 Micelaneous Sales and operadons Salanes.Saes and Oporatons Taxes and bane,* Sales & trainee malerials Travel and tolerlainment IT costs AllsostaneCoS am** OM Semlnistnitive Salaries. G & A TaxeS and beneNS Deprecation 8 arrerazaten ReCrlarq Insurance Legal & aCCCLantro &Ice *armee: Renlulilles CommuScabons Travel& toterlainment Miceleneeuti Bert tears Year 3 31-Jan-12 29-Feb-12 31-Mar-12 30-ADr-1: 416 an. an. Month 13 Month 14 Month 15 Month 16 $ 27.500 $ 27,500 $ 27,500 $ 27,500 0,125 4,125 4,125 4,125 75,000 75,030 75,000 75,000 2500 2500 1500 2,500 2,500 2,500 2,500 5.01 se" sso, 1,000 1,030 1,000 1,000 $ 110,125 S 110,125 $ 110,125 S 110125 $ 25,063 $ 25,063 $ 25,063 $ 25,063 Av 3x Isms 150% no% 3,759 3,759 3,759 3,759 1.0% 10% 1.sx 14,276 16,448 17,160 20,141 2500 no scoo 2,500 2,500 2,500 2,500 50x tsic 1.sx 21414 24,673 25,740 30,212 15,000 2000 sx 5x 2,100 2,100 2,100 2,100 5000 75(0 wox, 7,500 7,500 7,500 7,500 03% 05% 05% 100 100 100 100 $ 76,712 5 82 ,143 $ 98,921 $ 91,374 5 27,986 $ 27,986 $ 27,986 $ 27,986 3x 3x 4,198 4,198 4,198 4,198 1(00 11:00 Imo 2,000 2,030 2,00D 2,000 2500 SOM 7500 5,000 S,COCI 5,000 S. 1(00 MO 1010 2,000 2,030 2,00D 2,000 ova Ova 05% 100 100 100 100 $ 41.284 $ 41,284 $ 41.284 5 41.284 5 91,078 $ 91,478 $ 91,478 $ 91,478 3x5 3% 13,722 13,722 13,722 13,722 60,617 60,617 60,617 73,533 IS ex 563 - - - 1.0% 10% 10% 200 200 20D 200 7000 1000 moo 8,000 8,030 8,00D 8,030 soh 600 WO 10,200 10,200 10,20D 10,200 MOO 2C0a7 moo 20,000 20,000 20,00D 20,000 soh 500 soh 8,500 8,500 8,50D 8,500 5000 Mc* Imo 10,000 10,000 10,000 10,000 03% 01% 034 50 50 50 50 223,329 222,767 $ 222,767 5 235,683 341,326 346,194 $ 362,972 368,342 31-May-12 30 -Jun-12 31-101-12 31-Aue-12 30-Sep-12 31-Oct-12 30-Nov-12 31-04C-12 Total Month 17 $ 27,500 4,125 75,000 2,500 1,000 Month 18 5 27,500 0,125 75,000 2.500 1,000 Month 19 $ 27,500 4,125 75,0[0 2,5[0 1,000 Month 20 5 27,500 4,125 75000 2,500 1.000 Month 21 $ 27,500 4,125 75,000 2,500 - Month 22 5 27,500 4,125 75,000 2,500 1,000 Month 23 $ 27,500 4,125 75,000 2,500 1,030 Month 24 $ 27,50D 4,125 75,00D 2,50D - Month 24 $ 330,000 49,500 900,00D 30,00D 10,00D $ 110,125 5 110,125 $ 110,125 $ 110,125 $ 109,125 $ 110,125 5 110,125 $ 109,125 5 1 319 50D $ 25,063 5 25,063 $ 25,063 5 25,063 $ 25,063 5 25,063 5 25,063 $ 25,063 5 300,750 3,759 3,759 3,759 3,759 3,759 3,759 3,759 3,759 45,113 23,132 24,639 28,065 31,497 32,341 36,300 40,063 40,817 324,879 2,50D 2.500 2,500 2,500 2,503 2,500 2,500 2,50D 30,00D 34,698 36,959 42,097 47,245 48,512 54,449 60,095 61,226 487,319 15,000 15,0120 15,000 60,000 2,100 2,100 2,100 2,100 2,100 2,100 2,100 2,10D 25,20D 7,500 7.500 7,5[0 7,500 7,500 7,500 7,500 7,50D 90,00D 100 100 100 100 - 100 100 - 1,00D $ 98,852 117,619 $ 111,184 5 119,764 $ 136,775 5 131,771 5 156,179 5 142,965 5 1,364,261 $ 27,986 5 27,986 $ 52,214 5 52,214 $ 52,214 5 52,214 $ 52,214 $ 52,214 $ 481,200 4,198 4,198 7,832 7,832 7,832 7,832 7,832 7,832 72,180 2,00D 2,000 2,000 2,000 2,000 2,000 2,030 2,00D 24,00D 5,00D 5,000 5,0[0 5,000 5,000 5,000 5,030 5,000 60,00D 2,00D 2,000 2,000 2,000 2,000 2,000 2,030 2,000 24,00D 100 100 100 100 100 100 - 1,000 $ 41,284 $ 41.284 5 69,146 69.146 5 69,046 5 69.146 5 69.146 $ 69.046 5 662.380 $ 91,478 5 91,478 $ 91,478 $ 91,478 $ 91,478 5 91,078 $ 91,478 $ 91,478 5 1,097,738 13,722 13,722 13,722 13,722 13,722 13,722 13,722 13,722 164,661 73,533 73.333 84,800 84,800 84,8120 95,800 95,803 95,80D 944,250 - 3,625 - - - 4,188 200 200 200 200 - 200 200 - 2,00D 8,000 8,000 8,0[0 8,030 8,000 8,000 8,000 8,00D 96,00D 10,200 10,200 12,600 12,600 12,6[0 12,600 12,600 12,60D 136,80D 20,000 20,000 20,000 20,030 20,000 20,000 20,000 20,00D 240,000 8,500 8.500 10,5[0 10,500 10,500 10,500 10,500 10,50D 114,00D 10,000 10,000 10,000 10,030 10,000 10,000 10,000 10,000 120,000 50 50 50 50 - 50 50 - 500 $ 235,683 $ 235,683 $ 254,975 5 251,350 $ 251,100 $ 262,350 S 262,350 $ 262,100 $ 2,920 136 $ 375,820 394.587 $ 435,304. 440,259 $ 056,921. 463,266 487,675 $ 474,110 4,946,777 lattarCel Fs-uncial Km U501-2011 reel Sin 1A00011( Oolf head Budget CONFIDENTIAL EFTA00619624 lateMedi Elousences Inc. North America Division Overhead Expense F0/ fl eet Start Date: Research end development salines Taxes ard benefits anode tendon Travel a ertonarunon IA se ellaneete Afsketing Seams- Marketing Taxes and bablits Athertaangindree Proguel OattagInfigralfloe Public rotations Trade Shave Websrlo hasten & nee Travel & entertahrren heseellaneeue Sales and operations Salvos. Sales and Operate-is Taxes and Dental* Sobs & training meerals Travel and entenowen fronts heseellanetwe Oestrflei and eallattetIve Saloon- G & A TaxeS and ben eels Depreciation & amortization Recrtilth Insurance Legal & .3000tinth Office expenses semteines Communications Travel & entenovren Minellanetwe $ 275,350 S 275,350 S 275,100 $ 288,454 28&.7 $ 506,703 516,754 $ 533,024 $ 549,825 $ 559,435 real YWZ rear) 31-14n-13 28-Feb-13 31-Mar-13 30-44/-13 31-May-1: low as. outs Month 25 Month 26 Month 27 Month 29 Month 29 $ 27,500 $ 27,500 $ 27,500 $ 27,50D $ 27,500 4,125 4125 4,125 4,125 4,125 100,003 100,000 100,000 100,000 100,000 1500 1500 ne0 2,5[0 2.500 2,500 2,500 2,500 50% 50% 50% 1,000 1,000 1,000 1,030 $ 135,125 S 135,125 $ 134,125 $ 135,125 S 135,125 $ 25,063 S 25,063 $ 25,063 $ 25,063 $ 25,063 1% Deve 150% 150% 3,759 3,759 3,759 3,759 3,759 to% to% 1.5% 45,032 49,053 49,741 54,157 58,376 NM 2300 5000 5,000 5.000 5,(OD 5,000 5,030 to% 53% 1.5% 67,548 73,579 74,611 81,236 87,564 15,000 toto 5% 2,205 2.205 2,205 2,205 2,205 5000 7300 boos 10,000 10,000 10,030 10,000 10,000 0)% OS% 05% 103 100 - 100 100 $ 158,707 5 168,758 S 185,378 $ 181,520 S 192067 $ 52,214 $ 52.214 $ 52,214 $ 58,479 $ 58,479 1% 7,832 7.832 7,832 8,772 8,772 sorb Nos tom 3,000 3.000 3000 3,000 3,000 7500 WOO 7500 7,503 7.500 7,500 7,500 7,500 1003 1000 IOW 2,000 2,000 2,030 2,000 2,030 05% 05% 05% 100 100 100 100 5 72,646 $ 72.646 $ 72,546 $ 79.851 $ 79.851 $ 91,478 5 91478 $ 91,478 $ 91,478 $ 91,478 1% 13,722 13,722 13,722 13,722 13,722 106,800 106,800 106,800 117,867 117,867 150% - - - 936 - 10% 1.011. 10% 2C0 200 - 200 200 7000 Moo tc000 10,0[0 10,000 10,030 10,000 10,030 500 ice 600 12,600 12,600 12,600 13,200 13,200 am 7o0% How 20,0[0 20,000 20,030 20,00D 20,030 500 50) 500 10,500 10,500 10,500 11,00D 11,030 5000 1070o mom 10,0[0 10,000 10,(OD 10,00D 10,030 0)% 03% 03% 50 50 - 50 50 30-1un-13 31-1W-13 31-Aug-B 30-Sep-13 31-Oct-13 30-Nov-13 31-Dec-13 Total Month 30 Month 31 Month 32 Month 33 Month 34 Month 35 Month36 Month36 $ 27,500 $ 27,500 $ 27,500 $ 27,500 $ 27,500 $ 27,500 S 27,500 $ 330,000 4,125 4,125 4,125 4,125 4,125 4,125 4,125 49,500 100,00D 100,000 100,0[0 100,0130 100,003 100,000 100,000 1,200,030 2,50D 2,500 2,500 2,500 2,500 2,500 2,500 30,000 - 1,000 1,000 - 1,000 1,000 - 8,000 $ 134,125 S 135,125 $ 135,125. 5 134,125 $ 135,125. 5 135,125 S 134,125 $ 1,617,500 $ 25,063 5 25,063 $ 25,063 5 25,063 $ 25,063 5 25,063 $ 25,063 $ 300,750 3,759 3,759 3,759 3,759 3,759 3,759 3,759 45,113 58,938 63.302 67,466 67,576 71,936 76,095 76,073 737,744 5,00D 5,000 5,0[0 5,000 5,000 5,000 5,030 60,000 88,406 94,953 101,200 101,364 107,904 114,143 114,109 1,106,616 15,00D 15,000 15,000 60,000 2,205 2.205 2,205 2,205 2,205 2,205 2,205 26,460 10,000 10,000 10,003 10,000 10,000 10,000 10,000 120,000 - 100 100 - 100 100 800 $ 208,371 $ 20&. $ 214,793 $ 229.966 $ 225966 5 251,365 $ 236208 $ 2,457,483 $ 58,479 5 72,681 $ 72,681 $ 72,681 $ 72,681 $ 72,681 $ 72,681 $ 768,166 8,772 10,902 10,902 10,902 10,902 10,902 10,932 115,225 3,00D 3,000 LOCO 3,030 3000 3,000 3,000 36.030 7,50D 7,500 7,5[0 7,500 7,500 7,500 7,500 90,000 2,000 2,000 2,000 2,030 2,000 2,000 2,030 24,000 - 100 100 100 100 800 $ 79.751 $ 96,183 5 96,183 $ 96.083 5 96,183 $ 96.183 96.083 $ 1.034190 $ 91,478 5 91,478 $ 91,478 5 91,478 $ 91,478 5 91,478 $ 91,478 $ 1,097,738 13,722 13,722 13,722 13,722 13,722 13,722 13,722 164,661 117,867 117,867 117,867 117,867 128,867 128,867 128,867 1,414,200 2,125 3,063 200 200 200 1,600 10,000 10,000 10,0[0 10,000 10,000 10,000 10,000 120,000 13,20D 14,400 14,400 14,400 14,400 14,400 14,400 163,800 20,00D 20,000 20,003 20,000 20,000 20,000 20,030 240,000 11,00D 12,000 12,000 12,000 12,000 12,000 12,030 136,500 10,000 10,000 10,0[0 10,000 10,000 10,000 10,030 120,000 50 50 50 50 400 $ 287,267 5 291.842 $ 289,717 5 289,467 $ 300,717 5 300,717 $ 300,467 $ 3,461 961 $ 575,388 592,406 $ 600,693 615,516 $ 622,866 648,265 $ 632,758 $ 6,953,634 IntearCel Fs-uncial Km US 01-2011 reel SIP MOIlthho overhead Budget CONFIDENTIAL EFTA00619625 IntelliCell Biosciences Inc. North America Division Personnel Plan Forecast Start Date: Personnel Plan Start OE OE OE OE OE OE OE OE OE OE OE OE Excludes Owned Center Staff Salary Mar-11 Jun-11 Sap-11 Dec-11 Mar-12 Jun-12 Sep-12 Dec-12 Mar-13 Jun-13 Sep-13 Dec-13 Tax and Benefit Rate Ise% Research and development Research Director $ 150.000 I I 1 1 1 1 1 I 1 1 1 Lab Operations Director $ 180.000 I I I 1 1 1 1 1 I 1 1 1 I 2 2 2 2 2 2 2 2 2 2 2 Marketing VP Business development $ 175.000 I 1 1 1 1 1 1 1 I 1 1 1 Product Manager $ 125.000 1 I 1 I 1 I 1 I 1 I 1 I 2 2 2 2 2 2 2 2 2 2 2 Sales and operations VP Sales $ 100.000 I I I I I 2 2 2 3 3 3 Operations Director $ 75.000 I I I I 2 2 2 3 3 3 Customer Service Director $ 50.000 I 1 I I 2 2 2 2 3 3 Training Coordinator $ 120000 1 I I 2 2 2 2 3 3 Customer Service Rep $ 45.000 I I I 2 2 2 3 3 3 3 3 3 Assumes Outsourced Customer Service I 1 3 5 5 5 9 9 9 10 12 12 General and Administrative CEO $ 275.030 I I I I I I I I 1 I I 1 President $ 250.000 I I I I I I i I I I I 1 CFO $ 225.030 i I I I I I I I I I I 1 Controller $ 100.000 I 1 I 1 1 1 I 1 1 Accounting manager $ 60.000 1 1 1 I 1 1 I I 1 1 Accounts payable manager $ 50.000 I I 1 I 1 1 I I 1 1 Administrative assistants $ 45.000 2 2 2 2 3 3 3 3 3 3 3 3 5 5 7 8 9 9 9 9 9 9 9 9 COMPANY TOTAL 8 10 10 17 18 18 22 22 22 23 25 25 Departmental Summary S's Research and development 45.000 82.500 5 82.500 $ 82.500 5 82.500 $ 82.500 5 82.500 $ 82.500 $ 82.500 $ 82.500 $ 82.500 $ 82.500 1-/an-11 CONFIDENTIAL (For Internal Use Only) IntelfiCell Finanoal Plan US 01-2011 reyl.xlsx Personnel Plan EFTA00619626 Marketing 41750 75.000 5 75.000 $ 75.000 $ 75.000 $ 75.000 $ 75.000 $ 75.000 $ 75.000 $ 75.000 $ 75.000 $ 75.000 Sales and operations 11.250 11.250 5 42.500 $ 83.750 $ 83.750 $ 83.750 5 156250 $ 156.250 $ 156250 $ 175.000 5 217.500 $ 217.500 General and Administrative 210,000 210.000 $ 237.500 $ 262.500 $ 271750 $ 273.750 $ 271750 $ 273.750 $ 273.750 $ 273.750 $ 271750 $ 273.750 TOTAL $ 310.000 $ 378.750 5 437.500 $ 503.750 $ 515.000 $ 515.000 5 587.500 $ 587.500 $ 587.500 $ 608.250 5 848.750 $ 848.750 CONFIDENTIAL (For Internal Use Only) InlelliCell Financial Plan LIS 01-2011 revl.xlsx Personnel Plan EFTA00619627 IntelliCell Biosciences Inc. North America Division Three Year Launch Plan Forecast Start Date: Assumptions: 1.1an-11 Year 1 Year 2 Ye r 3 Month 3 Month 6 Month 9 Month 12 Month IS Month IS Month 21 Month 24 Month 21 Month 30 Month 33 Month 36 QV 31.Mar-it 34.3un-11 10Si-411 31-Dec-11 11-Mar-17 30-tun-l7 10.Seo.17 i1-Dec-17 31-Mar-13 TO-Jun.11 i0-sea-ti 11.Dec-IT Revenue and cost of cods assurn• Ions $ 20.000 , $ 20,000 5 20,000 5 20,000 $ 20,000 $ 20,000 LL $ 20,000 5 20,000 $ 20,000 $ 20.000 5 20,000 5 20.000 5 20.000 license Fee per Installation Avg. Treatment Revenue-Owned $ 8,000 $ 8,000 $ 8,000 $ 8,000 $ 8,000 $ 8.000 $ 8.000 $ 8.000 S 8.000 5 8.000 5 8.000 5 8,000 5 8,000 Avg. Processing Revenue- Licensed $ 2,500 $ 2.500 $ 2.500 $ 2.500 $ 2,500 $ 2,500 $ 2,500 $ 2,500 5 2,500 $ 2,500 $ 2,500 5 2,500 5 2,500 Facility Payments - Licensed mkts 30.0% 30% 30% 30% 30% 3036 3036 3036 30% 3D% 30% 30% 30% Physicians Payment-Owned Centers 10.0% 10% 10% 10% 10% 1036 1036 1036 10% 10% 10% 10% 10% Lab E I• meet Suite Sale Prim 5 95,000 $ 95000 $ 95 000 $ 95,000 $ 95,000 5 95.000 $ 95.000 5 95.000 5 95.000 5 95.000 5 95.000 5 95,000 5 95,000 Wholesale Price/Case $ 1,000 $ 1.00D 5 1,000 5 LOCO 5 1,000 $ Lam $ 1,000 5 1,000 5 1,000 5 1,000 5 1,000 5 1,000 5 1,000 Dis sable Cost Per Case ea. $ 400 5 400 5 000 5 400 $ 400 5 400 $ 400 5 400 5 400 5 400 5 400 5 400 5 400 Lab Equipment Suite -Cost 5 40.000 $ 40,000 S 40,000 5 40,000 5 40,000 $ 40.000 5 40.000 $ 40.000 5 40.000 5 40.000 5 40.000 5 40,000 5 40,000 QE Total Cases/Month 24 60 169 285 406 568 736 908 1.079 1.243 1,394 1.540 Quarterly Net Revenues $ 183,520 S 433,920 S 1.685.600 S 3.345.380 S 4.788.440 S 6.791.220 S 9.190.30) kA.A.A.WA)*VA.Vi.WA.>%A.>ttVakACA.CA.CA.C4.CA.CA.Sk.CA.C‘ CA.CA.C&CA.CA. 511.717.980 514.382.540 S 17.147.100 S 19.834.400 CA.CA.C‘ CA.CA.C4.(4%. S 22.410.380 CA.CA.C4.CAM Market rollout assumptions Initial Ofix ask tglmk ‘ARk wi,k oc ococ A.,k‘k ARk 1%1%1%1kt:1%1\1%1V\ ‘1%,1%,1i1. Owned Markets Opened 1.0 2 a: 2 CC 2 30 2.00 2.00 2.00 2.00 2.00 2.00 2.00 Licensed Markets Opened 30 3.01 5.01 5.03 3.00 3.09 2.00 2.00 2.00 2.00 2.00 2.00 Physician Markets Opened Cumulative -Owned 1.0 1.00 3.03 5.00 7.00 9.00 11.00 13.00 15.00 17.00 19.00 21.00 Cumulative -Licensed 3.0 6.00 11.00 16.00 19.00 22.00 24.00 26.00 28.00 30.00 32.00 34.00 Cumulative -Distributor Lab Installations/Owned Markel • : • ‘Z4;:ntn:n 10 100 1.00 1.00 1.0 1.00 1.0D 1.00 1.0 1.00 'DO 1.00 Lab Installations/Licensed Market SkteiZ;;;;;;;;;;;; 1.0 100 1.00 1.00 1.0 1.00 1.00 1.00 1.0 1.00 1.00 1.00 Lab Installations/Physician 5 95.000 1.0 1.00 1.00 1.00 1.0 1.00 1.00 1.00 1.0 1.00 1.00 1.00 Cumulative -Owned 1.0 1.00 3.00 5.03 /00 9.00 11.00 13.00 15.00 17.00 19.00 21.00 Cumulative Installations-Licensed 3.0 6.00 11.00 16.00 19.00 22.00 24.00 26.00 28.00 30.00 32.00 34.00 Cumulative Installations-Physicians - - - - - - - - - - Monthly Patients/ Wholly Owned No Blanks 16.0 16 A3 16.00 20.03 28.00 32.00 36.00 40.00 40.0) 40.0) 40.00 40.00 Monthly Patients/Installation-licensed No Blanks 8.0 12.03 15.00 20.03 25.00 30.00 32.0D 32.00 32.00 32.00 32D0 32.00 Monthly Patients/Physician Installations No Blanks 25% 5.0 25% 10.03 25% 15.03 25% 20.03 25% 25.00 25% 30.00 25% 30.00 25% 30.0D 25% 30.00 25% 30.00 25% 30.00 25% 30.00 25/6 Sales R assum lions Commission per Installation Commission - Processings 10% 10% 10% 10% 10% 10% 10% 1036 10% 10% 10% 10% 10% Commission - Banking 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% cca' CONFIDENTIAL IntelliCell Financial Plan US 01-2011 rev1.0sx Operating Assumptions EFTA00619628 IntelliCell Biosciences Inc. North America Division Three Year launch Plan Forecast Start Date. Assumptions 1-Jan-11 Off Year 1 YcJr 2 Year 3 Month 3 31 -Mar-11 Month 6 30-lun-11 Month 9 30-5i-o-11 Month 12 11 -Prc-Il Month 16 Month It: Month 21 Month 24 Month 27 Month 30 Month 33 Month 36 31-Mar-12 10-Jun-13 30•Sea•17 31-Der - IT 31•M u-1 1 TO-Jun 43 30.5mi-is 31 -Der -13 Owned center cost assom • Dons tr`tt.t 4kt Vt:ttt.•;.•`.tetittlett; ,,.. ,,, , *,.`.-,:`,:`,..t.tt;Stttattn; tttnattttttttttttrtttattttttnttatttnttnt= Rent $ 240,000 $ 240,003 S 240,000 S 240,000 S 240,000 $ 240,000 $ 240,000 S 240,000 5 240.000 5 240.000 5 240.000 5 240,000 5 240,000 Utilities 5 36,000 5 36,000 $ 36,000 $ 36,000 S 36,000 S 36.000 S 36.00D $ 36.000 5 36.000 5 36.000 5 36.000 5 36,000 5 36,000 Insurances 5 50,000 $ 50,000 $ 50,003 5 50,000 5 50,080 5 50,000 5 50,000 $ 50,000 5 50,000 5 50,000 5 50,000 5 50,000 5 50,000 Leased Equipment 5 130,000 5 80,000 5 80,080 5 80,000 5 80,000 5 80.000 5 80.000 $ 80.000 5 80.000 5 80.000 5 80.000 5 80,000 5 80,000 Misc 5 12,000 $ 12,000 $ 12,000 5 12,000 $ 12,000 $ 12.000 5 12.000 5 12.000 5 12.000 5 12.000 5 12.000 5 12,000 5 12,000 Physician Salary 5 100,000 $ 100000 5 loam 5 100,000 $ 10000D $ 100.000 $ 100.000 S 100.000 5 100.000 $ 100.000 5 100.000 5 100.000 5 100.000 Receptionist 5 40,000 $ 40.033 S 40,000 $ 40,000 $ 40030 S 40.030 S 40.00) S 40.00) $ 40.000 5 40.00) $ 40.00) $ 40.000 5 40.000 2 Lab Technician/Physician 5 120.000 $ 120,000 $ 120,000 r 120,000 5 120,000 5 120,000 $ 120,000 $ 120,000 5 120,000 $ 120,000 5 120,000 5 120,000 5 120,000 2 Nurses/Physician 5 150.000 $ 150033 $ 150000 5 150,003 $ 150033 $ 150.0)) S 150.00) S 150.00) 5 150.00) $ 150.00) 5 150.00) $ 150.000 $ 150.000 Total $ 828,000 $ 828.000 5 828.000 5 828,000 $ 828, $ 828,000 $ 828,000 $ 828,000 $ 828,000 ,, 5 828,000 $ 828,000 5 828.000 5 828.000 Bankin. & other sales assum • lion: ''`' .1'3 SS* 3. ..3 3..±. 3..i .S.S:: ••• 3:' Owned Stem Cell Banking 5 250.00 $ 250.00 S 250.00 S 250.00 250 $ 250.00 25000 25000 $ 250.00 5 250.00 5 250.00 5 250.00 $ 250.00 Enrollment Rate 80.0% 80.0% 80.0% 80.0% 80D% 80.0% 80.0% 80.0% 80.0% SOD% 80.0% 80.0% 80.0% Enrollment Fee 5 50.00 15.E 5 250.00 $ 50.00 $ 25000 $ 5000 $ 5000 $ 5000 S 25000 S 25000 S 25000 5 5000 $ 5000 $ 5000 $ 50.00 S 250.00 5 250.00 5 250.00 $ 25000 $ 50.00 $ 250.00 $ 50.00 5 50.00 $ 250.00 $ 250.00 $ 50.00 $ 250.00 Annual Attrition Rate Licensed Stem Cell Banking Enrollment Rate 80.0% 80.0% 80.0% 80.0% 80.0% 80.0% 80.0% 80.0% 80.0% 80.0% 800% BOA% 80.01 Enrollment Fee $ 50.00 15. 50.0% $ 5000 S 5000 S 50.00 S 5000 S MODS MOO S MOO $ MOO 50.0% 50.0% 50.0% 500% $ 50.00 $ 50.00 $ 50.00 $ 50.00 . ..4.: Annual Attrition Rate Product costs 50.0% 500% 50.0% 50.0% 500% 50D% 50.0',, -s - 50.0', Banking cost - % of reven = Mar 4,-S Assum • lions: Year 4 YNr$ ‘,,, ,,,,,,,,r ,,,,,,,,,,,,,,,,,, o^,,,,,,,,v,,,,,,,,‘, \'‘: : : : : : :V : : : : : : : \ ,,,,,,,,,,,,,,,,,,,,,, ',,,,,,,,,,,,,,,,, ,,,,,,,,,,,,,,,,,,,,, ,,,,,,,,,,,,,,,,,,,,,, 3'4'..i. %Nit : • V : : : :VU::: Nkix:::: \\•ii ,,,,,,,,,,,,, ,.-e..e..e.,‘ \i•i klkil Revenue growl& network Revenue growl& oducts Media efficiency ,,,,"', ,,. ,,,,,,''''''''"''' ,,,,, ,,,,,,. , ,, , , ,, ,,,,,,,,,,,,. ,,,,,,,,,,,,. , ,, , , ,, , 1 -'''''' 5,-, ' .. \ ‘‘•'-:: 6. SG&A rowlh CELL CONFIDENTIAL IntelliCell Financial Plan US 01-2011 (mil sisx Operating Assumptions EFTA00619629 IntelKell Biosdences Inc. North America Division Three Year Launch Plan Forecast Start Date: CURRENT ASSETS Receivables- network Receivables-product sales Inventory Prepaid expenses Marketing Insurance Rent CAPITAL BUDGET Furniture & fixtures-employees Computers-employees Telephony Computer Network Center Furnishings (5100K Each) Lab equipment (5300K Each) CURRENT LIABILITIES Accounts payable Accrued expenses Payroll Expenses Interest LONG TERM DEBT Equipment 1-Jan-11 7.0 days days 60.0 days 15 days 60 days 30 days 31-Mar-11 30-1un-11 30-Sep-11 31-Dec-11 31-Mar-12 30-Jun-12 30-Sep-12 31-Dec-12 31-Mar-13 $ 2,500 $ 20,000 $ 5,000 $ 10,000 $ 7,500 $ 2,500 $ $ 10,000 $ $ $ 1,500 $ 12,000 $ 3,000 $ 6,000 $ 4,500 $ 1,500 $ $ 6,000 $ $ $ 50,000 $ 25,000 $ 25,000 $ tstt000 $ 500,000 $ 500,000 $ 500,000 $ 500,000 $ 500,000 $ 500,000 $ 500,000 $ 500,000 $ 500,000 $ 40,000 $ 120,000 $ 120,000 $ 320,000 $ 280,000 $ 200,000 S 200,000 $ 160,000 $ 160,000 $ 160,000 Financed % $ 652,000 S 628,000 $ 861,000 $ 792,000 $ 704,000 $ 775,000 676,000 $ 660,000 $ 660,000 15.0 Days variable costs (excl media) 7.0 Days 15.0 Days SG&A 15.0 Days SG&A Principal Start Months Interest Conversion Warrants Payment Sales Expense 70.0% $ 290,000 60.0 8% SHAREHOLDER'S EQUITY Non Controlling Common stock Shares Start Par Price Proceeds Sales Exp Interest Initial Equity- Par .001 16,000,000 12/31/10 $ 0.001 0.01 $ 16,000 0.0% 0.0% Intial Investor Round 3,500,000 12/31/10 $ 0.001 1.50 $ 5,250,000 10.0% 0.0% CONFIDENTIAL IntelliCell Financial Nan US 01-2011 rev1.xisx Balance Sheet Assumptions EFTA00619630